過活動膀胱患者のソリフェナシンからフェソテロジンへの変更の有用性

DOI 機関リポジトリ (HANDLE) Web Site オープンアクセス

書誌事項

タイトル別名
  • The Efficacy of Fesoterodine Switched from Solifenacin for Overactive Bladder Patients
  • カカツドウ ボウコウ カンジャ ノ ソリフェナシン カラ フェソテロジン エ ノ ヘンコウ ノ ユウヨウセイ

この論文をさがす

説明

We investigated the efficacy of Fesoterodine, in 51 patients who did not respond to treatment with Solifenacin from January 2017 to December 2018. We assessed the overactive bladder symptom score (OABSS), thirst, constipation, and residual urine at baseline, as well as at 3 and 6 months from the start of drug administration. The mean age of the patients was 83. 0±6. 55 years. The OABSS indicated significant improvement in urge urinary incontinence and residual urine at 6 months, and significant aggravation in urgency at 3 months. Thus, Fesoterodine is considered useful for patients who did not respond to treatment with Solifenacin.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 66 (6), 165-170, 2020-06-30

    泌尿器科紀要刊行会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ